Video & Transcript Research : 'nonopioid analgesics'
Page 1 of 3
KY
Kentucky 2026 Regular Session
House Legislative Session Day 59 (4-14-26) - Part 1
Kentucky House Floor Meeting
Bills:
SB141, SB124, SB56, SJR116, SB94, SB37, SB127, SB197, SB66, SB70, SB133, SB160, SB214, SB312, SB52, SJR62, SJR75
Keywords:
legal advertisements, tax rates, public hearings, transparency, local government, sick leave, education, teacher retirement, benefits, employee compensation, Medicaid, nonopioid analgesics, pain management, health care regulation, utilization controls, physician shortage, health care access, medically underserved areas, medical education, workforce development
MN
Minnesota 2025-2026 Regular Session
House Health Finance and Policy Committee 2/25/26 - Part 2
Health Finance and Policy
Keywords:
hospital moratorium, hospital construction, bed capacity, hospital expansion, health care facilities, hospital licensing, safety-net hospital, level I trauma center, Ramsey County, Minnesota health law, hospital beds, new hospital exception, certificate of need, inpatient capacity, emergency care, trauma services, health system regulation, state moratorium, hospital modernization, health infrastructure
MN
Minnesota 2025-2026 Regular Session
House Health Finance and Policy Committee 2/25/26 - Part 1
Health Finance and Policy
Transcript Highlights:
- No patient should face delays when accessing nonopioid treatments.
- So, with us today is Chris Fox of Voices for Nonopioid Choices.
- </c><00:25:15.520><c> I'd</c><00:25:15.679><c> love</c> Voices for Nonopioid Choices.
- I'd love Voices for Nonopioid Choices.
- </c> working on this new um nonopioid working on this new um nonopioid options. options. options.
Keywords:
hospital moratorium, hospital construction, bed capacity, hospital expansion, health care facilities, hospital licensing, safety-net hospital, level I trauma center, Ramsey County, Minnesota health law, hospital beds, new hospital exception, certificate of need, inpatient capacity, emergency care, trauma services, health system regulation, state moratorium, hospital modernization, health infrastructure
KY
Kentucky 2026 Regular Session
House Legislative Session Day 60 (4-15-26) - Part 1
Kentucky House Floor Meeting
Transcript Highlights:
- in favor of opioid analgesics.
- analgesics analgesics in<00:49:57.240><c> favor</c><00:49:57.680><c> of</c><00:49:57.920><c> opioid</
- c><00:49:58.600><c> analgesics.
- </c><00:49:59.720><c> It</c><00:50:00.600><c> um</c> in favor of opioid analgesics.
- It um in favor of opioid analgesics.
Bills:
SB141, SB124, SB56, SJR116, SB94, SB37, SB127, SB197, SB66, SB70, SB133, SB160, SB214, SB312, SB52, SJR62, SJR75
Keywords:
legal advertisements, tax rates, public hearings, transparency, local government, sick leave, education, teacher retirement, benefits, employee compensation, Medicaid, nonopioid analgesics, pain management, health care regulation, utilization controls, physician shortage, health care access, medically underserved areas, medical education, workforce development
KY
Kentucky 2026 Regular Session
House Legislative Session Day 60 (4-15-26) - Part 2
Kentucky House Floor Meeting
Bills:
SB141, SB124, SB56, SJR116, SB94, SB37, SB127, SB197, SB66, SB70, SB133, SB160, SB214, SB312, SB52, SJR62, SJR75
Keywords:
legal advertisements, tax rates, public hearings, transparency, local government, sick leave, education, teacher retirement, benefits, employee compensation, Medicaid, nonopioid analgesics, pain management, health care regulation, utilization controls, physician shortage, health care access, medically underserved areas, medical education, workforce development
KY
Kentucky 2026 Regular Session
House Legislative Session Day 59 (4-14-26) - Part 2
Kentucky House Floor Meeting
Bills:
SB141, SB124, SB56, SJR116, SB94, SB37, SB127, SB197, SB66, SB70, SB133, SB160, SB214, SB312, SB52, SJR62, SJR75
Keywords:
legal advertisements, tax rates, public hearings, transparency, local government, sick leave, education, teacher retirement, benefits, employee compensation, Medicaid, nonopioid analgesics, pain management, health care regulation, utilization controls, physician shortage, health care access, medically underserved areas, medical education, workforce development
KY
Kentucky 2026 Regular Session
Senate Legislative Session, Day 4 (1-9-26)
Kentucky Senate Floor Meeting
MN
Minnesota 2025-2026 Regular Session
House Health Finance and Policy Committee 3/10/25
Health Finance and Policy
Transcript Highlights:
- He said the bill establishes a nonopioid directive form. It is simple and easy to fill in.
- </c><01:08:58.679><c> directive</c><01:08:59.359><c> form</c> establishes a nonopioid directive form
- establishes a nonopioid directive form again<01:09:00.679><c> it's</c><01:09:01.120><c> simple</c><01
- </c> issues with this language a nonopioid issues with this language a nonopioid directive<01:09:34.040
- This bill will allow patients the ability to create a nonopioid directive, ensuring that they are not
Keywords:
HF696, rural EMS, ambulance, emergency medical services, uncompensated care, payment pool, rural health, Office of Emergency Medical Services, public safety answering point, PSAP, nontransport, unpaid ambulance calls, EMS reimbursement, rural ambulance provider, general fund appropriation, Minnesota health finance, specialized life support, metropolitan counties, emergency response funding, HF1429
CO
Colorado 2026 Regular Session
Colorado Senate 2026 Legislative Day 094 Apr 18th, 2026
Colorado Senate Floor Meeting
Transcript Highlights:
- ><c> subject</c> Nonopioid treatments are often subject Nonopioid treatments are often subject to<00:
- </c><01:14:48.000><c> That's</c><01:14:48.320><c> nonopioid.</c> "For pain. That's nonopioid.
- </c> four companies that offer a nonopioid four companies that offer a nonopioid drug<01:17:30.239><c
- </c> nonopioid drugs. nonopioid drugs.
- </c> appropriate nonopioid prescription drug. appropriate nonopioid prescription drug.
NH
New Hampshire 2025 Regular Session
Senate Health and Human Services (03/12/2025)
Health and Human Services
Transcript Highlights:
- That, um, prescribes specific, not so much nonopioid, but opioid.
- but opioid I just feel like nonopioid but opioid I just feel like that<00:15:09.120><c> um</c><00:15
- And nonopioid both allowed if you really wanted to go after eliminating the opioid prescribing through
- telehealth without that follow-up in-person visit, you could strike that opioid and or nonopioid and
- just leave it as nonopioid controlled medication in the language, at least providing, not my opinion
MS
Transcript Highlights:
- The first we're going to hear about nonopioid pain medications.
- The first we're going to hear about nonopioid pain medications.
- One of the things we have to be careful with on this is making sure that we don't say that nonopioids
- We don't want nonopioids to have to step through opioids for step therapy, but they probably do need
- </c> instead of nonopioids. instead of nonopioids.
MN
Minnesota 2025-2026 Regular Session
House Judiciary Finance and Civil Law Committee 3/20/25
Judiciary Finance and Civil Law
Transcript Highlights:
- </c><00:09:43.360><c> of</c><00:09:43.560><c> these</c><00:09:44.160><c> um</c><00:09:44.560><c> nonopioid
- </c> you have one of these um nonopioid you have one of these um nonopioid directives<00:09:46.040><c
- 28.760><c> so</c><00:10:28.880><c> you</c><00:10:29.000><c> have</c><00:10:29.120><c> to</c> that nonopioid
- directive so you have to that nonopioid directive so you have to have<00:10:30.600><c> H</c><00:10:31.040
- :10:40.200><c> a</c> opioid to a person who actually has a opioid to a person who actually has a nonopioid
Keywords:
nonopioid directive, opioid refusal, opioid-free care, pain management, health care directive, advance directive, patient autonomy, informed consent, substance use disorder, opioid epidemic, prescriber immunity, provider liability, emergency medical services, EMS, health record, Minnesota Department of Health, health care agent, medical power of attorney, Metropolitan Council, Minnesota government data practices
KY
Kentucky 2025 Regular Session
Medicaid Oversight and Advisory Board (12-10-25)
Transcript Highlights:
- This includes not only opioids but also leads to the crisis of addiction with nonopioid anti-inflammatory
- implementing utilization<00:53:03.760><c> controls</c><00:53:04.319><c> for</c><00:53:04.640><c> nonopioid
- </c><00:53:05.520><c> pain</c> utilization controls for nonopioid pain utilization controls for nonopioid
- reason that opioid-based medications continue to be the standard of care is because the economics of nonopioid
- reason that opioid-based medications continue to be the standard of care is because the economics of nonopioid
Summary:
The Medicaid Oversight Advisory Board met with a quorum, approved the November 12 minutes by voice vote, and then heard a presentation from former Governor Ernie Fletcher and Dave Johnson on Medicaid reimbursement for substance use disorder (SUD) treatment. Fletcher argued that addiction should be treated as a chronic disease requiring a longer continuum of care, not just short residential stays, and said recovery should combine clinical treatment with social supports such as housing, transportation, employment, peer coaching, and recovery housing. He cited data on overdose trends, low treatment rates, and high costs for people with SUD, and said current reimbursement models create poor incentives and do not adequately support long-term recovery or measure outcomes well.
Fletcher proposed a “carve through” model administered at the MCO level with standardized metrics, data sharing, and an independent recovery coordinator that would assess patients, coordinate care, and connect them to clinical and social recovery services. He suggested using bundled payments, shared savings, and partial risk arrangements, with recovery housing reimbursed on a PMPM or weekly basis and funded in part through existing Medicaid spending and other sources such as opioid abatement funds. He also emphasized peer support, telemedicine, criminal justice coordination, workforce and education supports, and the use of technology, including text messaging and possibly AI, to maintain long-term follow-up and identify relapse risk.
Members questioned how the model would work in practice, especially the education and staffing requirements for recovery coordinators, reimbursement levels, and how many patients each coordinator or peer would serve. Fletcher said peers could be certified and would need additional training in assessments such as ASAM and recovery residence standards, but he did not give a precise salary figure, saying the market and bundled rates would determine that. He also said follow-up should continue for years, noting relapse risk over the first 18 to 24 months and that meaningful employment and ongoing peer contact help sustain recovery. No formal vote or action was taken on the substance use presentation.
KY
Kentucky 2026 Regular Session
Senate Legislative Session Day 26 (2-12-26)
Kentucky Senate Floor Meeting
MN
Minnesota 2025-2026 Regular Session
Committee on Commerce and Consumer Protection - 03/05/26
Commerce and Consumer Protection
Transcript Highlights:
- treatment as they do proven nonopioid treatment as they do for<00:18:02.880><c> opioids</c><00:18:03.919
- </c><00:18:10.400><c> Pain</c> accessing nonopioid treatment. Pain accessing nonopioid treatment.
- </c><00:18:14.480><c> for</c><00:18:14.720><c> a</c><00:18:14.880><c> patient,</c> prescribes a nonopioid
- for a patient, prescribes a nonopioid for a patient, they<00:18:15.760><c> aren't</c><00:18:16.000><
- </c> health plans are offering nonopioids health plans are offering nonopioids without<00:18:26.320><
FL
Florida 2025 Regular Session
February 11, 2025 - 01:00 PM
Transcript Highlights:
- placement of spacers, pulpotomies on primary teeth, and dispensing and administering non-opioid analgesics
- On line 772, it talks about dental therapists can dispense and administer non-opioid analgesics, including
- On line 772, it talks about dental therapists can dispense and administer non-opioid analgesics, including
Summary:
The Health Professions and Programs Subcommittee heard and advanced three bills. HB 21 would create a new licensed profession of dental therapy under the Department of Health and Board of Dentistry, allowing trained dental therapists to provide a limited scope of care under a supervising Florida-licensed dentist through a collaborative management agreement. Sponsor Rep. Cheney argued the bill would help address severe dental shortages and improve access in underserved areas; opponents from the Florida Dental Association and oral surgery groups warned that the bill would allow irreversible procedures by less-educated providers and could compromise patient safety. Supporters, including dentists, hygienists, and community health center leaders, said dental therapists would expand access and free dentists to handle more complex care. An amendment was adopted to require proof of local anesthesia training, adverse-incident reporting, and updated background screening language. The bill was reported favorably as amended by a 14-1 vote.
The committee then considered HB 27, which creates the Social Work Licensure Interstate Compact to allow licensed social workers to practice across member states, including through telehealth, and to help military families and address workforce shortages. Supporters from the National Association of Social Workers and other advocates said the compact would improve mobility, reduce administrative burdens, and expand access to mental health services, especially in underserved and rural areas. A technical amendment restoring model language and setting an effective date of July 1, 2025 was adopted, and the bill was reported favorably as amended on a 15-0 vote.
Finally, the committee heard HB 29, the public-records companion to the social work compact, which creates exemptions needed for compact compliance and allows the compact commission or its committees to meet in closed session when discussing information exempt under law. After a technical amendment authorizing closed meetings for exempt matters was adopted, the bill was reported favorably as amended on a 15-0 vote. The meeting then adjourned.
NH
New Hampshire 2026 Regular Session
House Finance Division I (02/09/2026)
Transcript Highlights:
- are for opioid treatments, to try to bring down barriers and help people get more access to those nonopioid
- Um, just to make sure that there are no restrictions that are more stringent for nonopioid treatments
- are for opioid treatments, to try to bring down barriers to help people get more access to those nonopioid
- So, obviously reading the fiscal note and hearing your testimony, are we confident that nonopioid pain
- if this bill were to pass, would um health care providers be in a more of a position to recommend nonopioid
Summary:
The committee first heard testimony from State Treasurer Monica Misipelli on House Bill 1042, which would increase the contingent credit limit for the BFA. She explained that under RSA 66 the state’s debt capacity is capped at 10% of unrestricted revenue, and that guaranteed debt counts in the calculation even though it is not direct debt. She said the state currently has about 65% of its capacity used, roughly $120 million of remaining room, and that raising the BFA contingent credit limit from $200 million to $450 million would reduce that capacity. She noted the state’s debt-to-revenue ratio is about 4.2%, that the state’s credit rating is not immediately affected by the guarantee program unless the state actually has to assume the liability, and suggested unused guarantee authorizations, such as one for the Peace Development Authority, could be reviewed in the future.
Members asked whether a credit guarantee affects bonding ability like actual debt, what the usual debt level is relative to the statutory cap, and whether the increase would crowd out future capital borrowing. Misipelli answered that guarantees are included in the formula and do affect available capacity, though the current ratio remains manageable. She also said she had been using a $120 million benchmark for capital budget planning and was now modeling $130 million in future state debt. When asked whether the full $250 million increase was necessary, she deferred to the BFA, saying the question should be answered by the agency.
James Key Wallace, executive director of the New Hampshire BFA and interim commissioner of Business and Economic Affairs, then testified in support of the bill. He said the request was driven by larger project costs over the last several decades, with construction inflation causing guarantees to be used up in bigger chunks, and by the fact that the BFA has been close to its current cap. He said the agency does not use taxpayer funds, has never had a payout on a guarantee in nearly 35 years, and requires collateral, reserves, and an 80% loan-to-value buffer. He told members the Senate had a similar bill to raise the limit to $400 million and that the BFA considered that range acceptable. In response to questions, he said a smaller increase such as $150 million would cover known transactions but might not provide enough runway for future opportunities, and he confirmed the bill was brought at the BFA’s request. He also said businesses consider housing availability when deciding whether to locate in New Hampshire, since housing and workforce are key location factors.
At the end of the work session, the chair closed House Bill 1042 and opened House Bill 241, a bill on health insurance coverage of pain management services for chronic pain. Representative Nagel began introducing the bill and asked for copies of the treasurer’s debt-capacity report, but the transcript cuts off before any further action on HB 241.
KY
Kentucky 2026 Regular Session
House Legislative Session Day 51 (3-20-26)
Kentucky House Floor Meeting
Transcript Highlights:
- Senate Bill 56, Senator Neil, an act relating to utilization contracts or controls for nonopioid analgesics
- contracts or act relating to utilization contracts or controls<00:06:18.800><c> for</c><00:06:19.440><c> nonopioid
- /c><00:06:20.400><c> analesics</c><00:06:21.199><c> in</c><00:06:21.360><c> the</c> controls for nonopioid
- analesics in the controls for nonopioid analesics in the Medicaid<00:06:22.000><c> program.
MS
Transcript Highlights:
- And then we're also going to have a brief briefing on nonopioid medications and some, um, a stimulator
KY
Kentucky 2026 Regular Session
Senate Standing Committee on Health Service (2-11-26)
Transcript Highlights:
- department, and the Medicaid state pharmacy benefit manager from denying coverage for a non-opioid analgesic
- in favor of an opioid analgesic or establishing more restrictive or more extensive utilization controls
- for non-opioid analgesics than the least restrictive or extensive utilization controls for any opioid
- or narcotic analgesic.
Summary:
The Senate Standing Committee on Health Services met with a quorum and first moved through administrative regulations without comment. The committee then heard Senate Bill 56, sponsored by Senator Gerald Neal, which would require Medicaid and its managed care entities to treat non-opioid pain medications on equal footing with opioid analgesics by prohibiting more restrictive coverage controls, prior authorization, or step therapy for non-opioids. Neal argued the bill would improve access to safer pain treatment options and reduce the risk of opioid use disorder, and Billy O'Brien of Young People in Recovery testified in support, describing personal experiences where non-opioid options were difficult to obtain despite a desire to avoid opioids. After discussion, the bill received a motion and second and passed the committee on a 10-0 vote.
The committee then took up Senate Bill 72, sponsored by Senator Don Douglas and presented with Greg Chaffin of Alliance Defending Freedom. Douglas described the bill as a provider recruitment and retention measure intended to protect health care workers from being compelled to act against their conscience and to address workforce shortages and pressure in health care settings. He said the bill would protect individual beliefs while maintaining professionalism. A large number of witnesses then testified, and the chair limited public comments to two minutes each because of the number of speakers and the controversy surrounding the bill.
Most public testimony opposed SB 72. Speakers including representatives of the Kentucky Council of Churches, a psychologist, an ordained minister and nurse, a nurse practitioner, and an ACLU policy strategist argued the bill was overly broad, could allow refusals of care by a wide range of health care workers, and could delay or deny treatment, especially for vulnerable patients and in rural or emergency settings. Several cited concerns about discrimination, patient safety, and the lack of adequate protections for patients. One witness recounted the death of an 18-year-old pregnant patient as an example of the harm that can result from delayed care. The transcript ends during additional testimony on SB 72, before any committee vote or final action on that bill is shown.